🇺🇸 FDA
Patent

US 12280089

Dry powder formulation of caveolin-1 peptides and methods of use thereof

granted A61KA61K38/08A61K38/10

Quick answer

US patent 12280089 (Dry powder formulation of caveolin-1 peptides and methods of use thereof) held by The Board of Regents of the University of Texas System expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K38/08, A61K38/10, A61K38/177, A61K45/06